Cargando…

Estimating HIV Management and Comorbidity Costs Among Aging HIV Patients in the United States: A Systematic Review

BACKGROUND: As life expectancy of patients infected with human immunodeficiency virus (HIV) approaches that of the general population, the composition of HIV management costs is likely to change. OBJECTIVES: To (a) review treatment and disease management costs in HIV, including costs of adverse even...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ward, Thomas, Sugrue, Daniel, Hayward, Olivia, McEwan, Phil, Anderson, Sarah-Jane, Lopes, Sara, Punekar, Yogesh, Oglesby, Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2020
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391104/ https://www.ncbi.nlm.nih.gov/pubmed/32011956 http://dx.doi.org/10.18553/jmcp.2020.26.2.104

Ejemplares similares

Cost-effectiveness and budget impact of dolutegravir/lamivudine for treatment of human immunodeficiency virus (HIV-1) infection in the United States
por: Butler, Karin, et al.
Publicado: (2021)

Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model Design
por: Sugrue, Daniel M., et al.
Publicado: (2019)

Serum potassium as a predictor of adverse clinical outcomes in patients with increasing comorbidity burden
por: Tafesse, Eskinder, et al.
Publicado: (2020)

Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus
por: McEwan, Phil, et al.
Publicado: (2017)

Cost of noninfectious comorbidities in patients with HIV
por: Guaraldi, Giovanni, et al.
Publicado: (2013)

Estimating the Cost-Effectiveness of One-Time Screening and Treatment for Hepatitis C in Korea
por: Kim, Do Young, et al.
Publicado: (2017)

The Potential Cost-Effectiveness of HIV Vaccines: A Systematic Review
por: Adamson, Blythe, et al.
Publicado: (2017)

The cost of comorbidities in treatment for HIV/AIDS in California
por: Zingmond, David S., et al.
Publicado: (2017)

Comparative efficacy and safety and dolutegravir and lamivudine in treatment naive HIV patients
por: Radford, Matthew, et al.
Publicado: (2019)

Costs and Cost-Effectiveness of Biomedical, Non-Surgical HIV Prevention Interventions: A Systematic Literature Review
por: Bozzani, Fiammetta M., et al.
Publicado: (2022)

Assessing the Long-Term Impact of Treating Hepatitis C Virus (HCV)-Infected People Who Inject Drugs in the UK and the Relationship between Treatment Uptake and Efficacy on Future Infections
por: Bennett, Hayley, et al.
Publicado: (2015)

2488. Virologic Failure in ART Naïve Patients Initiating on a Dolutegravir or Elvitegravir-Based Regimen
por: Wohlfeiler, Michael, et al.
Publicado: (2019)

Costs and Healthcare Resource Use Associated with Risk of Cardiovascular Morbidity in Patients with Chronic Kidney Disease: Evidence from a Systematic Literature Review
por: Darlington, Oliver, et al.
Publicado: (2021)

Improving access to antiretrovirals in China: economic analyses of dolutegravir in HIV-1 patients
por: Punekar, Yogesh Suresh, et al.
Publicado: (2019)

Costs of implementing community-based intervention for HIV testing in sub-Saharan Africa: a systematic review
por: Uzoaru, Florida, et al.
Publicado: (2021)

External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions
por: Lopes, Sandra, et al.
Publicado: (2020)

Cost-effectiveness of the long-acting regimen cabotegravir plus rilpivirine for the treatment of HIV-1 and its potential impact on adherence and viral transmission: A modelling study
por: Parker, Ben, et al.
Publicado: (2021)

Characterizing unmet medical need and the potential role of new biologic treatment options in patients with ulcerative colitis and Crohn’s disease: a systematic review and clinician surveys
por: Gordon, Jason P., et al.
Publicado: (2015)

Authors’ reply to Comment on “External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions”
por: Lopes, Sandra, et al.
Publicado: (2020)

COPD management costs according to the frequency of COPD exacerbations in UK primary care
por: Punekar, Yogesh Suresh, et al.
Publicado: (2014)

Cost-Effectiveness of Anti-retroviral Adherence Interventions for People Living with HIV: A Systematic Review of Decision Analytical Models
por: Ahmed, Ali, et al.
Publicado: (2023)

Estimating the Clinical and Economic Benefit Associated with Incremental Improvements in Sustained Virologic Response in Chronic Hepatitis C
por: McEwan, Phil, et al.
Publicado: (2015)

Estimating the cost of diagnosing HIV at birth in Lesotho
por: Tchuenche, M., et al.
Publicado: (2018)

588. Retrospective Analysis of Clinical Characteristics and Treatment Patterns Among HIV Patients with Commercial and Medicare Advantage Health Insurance in the United States
por: Priest, Julie, et al.
Publicado: (2018)

The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-on Therapy to Metformin in Patients with Uncontrolled Type 2 Diabetes Mellitus
por: Gordon, Jason, et al.
Publicado: (2016)

Estimation of the Incremental Cumulative Cost of HIV Compared with a Non-HIV Population
por: Cohen, Joshua P., et al.
Publicado: (2020)

Effects of HIV and non-communicable disease comorbidity on healthcare costs and health experiences in people living with HIV in Zimbabwe
por: Gonah, Laston, et al.
Publicado: (2020)

A Narrative Systematic Literature Review: A Focus on Qualitative Studies on HIV and Medication-Assisted Therapy in the United States
por: Cernasev, Alina, et al.
Publicado: (2021)

Diagnoses, prevalence, and state-based federal spending for HIV prevention and treatment in the United States, 2006–2009
por: Oglesby, Willie H, et al.
Publicado: (2014)

Comorbidities and costs in HIV patients: A retrospective claims database analysis in Germany
por: Christensen, Stefan, et al.
Publicado: (2019)

Comparative efficacy and safety of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: a systematic review and network meta-analysis
por: Snedecor, Sonya J., et al.
Publicado: (2019)

Estimating the costs and cost‐effectiveness of HIV self‐testing among men who have sex with men, United States
por: Shrestha, Ram K, et al.
Publicado: (2020)

Estimating the Costs of Implementing Comprehensive Primary Care: A Narrative Review
por: Martsolf, Grant R., et al.
Publicado: (2019)

Systematic Review of Programs Treating High-Need and High-Cost People With Multiple Chronic Diseases or Disabilities in the United States, 2008–2014
por: Bleich, Sara N., et al.
Publicado: (2015)

Ageing with HIV: Medicine Optimisation Challenges and Support Needs for Older People Living with HIV: A Systematic Review
por: Sarma, Priya, et al.
Publicado: (2023)

The effect of hyperkalemia and long inter-dialytic interval on morbidity and mortality in patients receiving hemodialysis: a systematic review
por: Bem, Danai, et al.
Publicado: (2021)

Evaluation of Insulin Use and Value for Money in Type 2 Diabetes in the United Kingdom
por: Gordon, Jason, et al.
Publicado: (2013)

Service delivery interventions to improve adolescents' linkage, retention and adherence to antiretroviral therapy and HIV care
por: MacPherson, Peter, et al.
Publicado: (2015)

Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis
por: Nickel, Katharina, et al.
Publicado: (2021)

Screening tools for HIV-associated neurocognitive disorders among adults living with HIV in sub-Saharan Africa: A scoping review
por: Mwangala, Patrick N., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_48oqbn8v4hajcufdqokd4gklc5